Last reviewed · How we verify
gentamicin-collagen sponge and levofloxacin
At a glance
| Generic name | gentamicin-collagen sponge and levofloxacin |
|---|---|
| Also known as | Collatamp G |
| Sponsor | Innocoll |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Safety and Efficacy of an Antibiotic Sponge in Diabetic Patients With a Mild Infection of a Foot Ulcer (PHASE2)
- The Safety and Efficacy of an Antibiotic Sponge in Diabetic Patients With Moderately Infected Foot Ulcers (PHASE2)
- Efficacy and Safety of Garamycin® Sponge in Diabetic Patients With a Moderate or Severe Foot Ulcer Infection (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- gentamicin-collagen sponge and levofloxacin CI brief — competitive landscape report
- gentamicin-collagen sponge and levofloxacin updates RSS · CI watch RSS
- Innocoll portfolio CI